Home » Stocks » Akers Biosciences

Akers Biosciences Inc. (AKER)

Stock Price: $4.99 USD -0.03 (-0.60%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed
After-hours: $5.01 +0.02 (0.40%) Aug 4, 7:25 PM

Stock Price Chart

Key Info

Market Cap 30.56M
Revenue (ttm) 1.33M
Net Income (ttm) -6.51M
Shares Out 6.13M
EPS (ttm) -6.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $4.99
Previous Close $5.02
Change ($) -0.03
Change (%) -0.60%
Day's Open 5.01
Day's Range 4.95 - 5.15
Day's Volume 468,801
52-Week Range 1.55 - 16.32

More Stats

Market Cap 30.56M
Enterprise Value 23.39M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 6.13M
Float 4.42M
EPS (basic) -6.26
EPS (diluted) -6.29
FCF / Share -1.93
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 127,768
Short Ratio 0.14
Short % of Float 1.87%
Beta 0.40
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 23.01
PB Ratio 4.97
Revenue 1.33M
Operating Income -6.55M
Net Income -6.51M
Free Cash Flow -4.29M
Net Cash 7.17M
Net Cash / Share 1.17
Gross Margin 36.04%
Operating Margin -493.19%
Profit Margin -490.00%
FCF Margin -322.66%
ROA -48.14%
ROE -110.49%
ROIC -119.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$768.00*
Low
768
Current: $4.99
High
768
Target: 768.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue1.581.673.352.962.124.433.581.561.79
Revenue Growth-5.32%-50.35%13.3%39.99%-52.23%23.74%128.75%-12.38%-
Gross Profit0.480.130.951.881.163.251.660.560.83
Operating Income-3.95-10.06-6.61-3.33-9.68-3.20-1.81-2.74-4.21
Net Income-3.89-10.85-7.37-3.30-9.31-3.14-1.53-2.56-3.63
Shares Outstanding0.610.490.050.030.030.020.010.010.01
Earnings Per Share-6.35-22.28-150.95-117.11-347.49-126.71-184.31-430.05-666.19
Operating Cash Flow-3.07-8.50-5.08-4.17-5.13-3.88-2.73-1.00-2.45
Capital Expenditures0.01-0.07-0.05-0.12-0.11-0.02-0.12-0.01-0.06
Free Cash Flow-3.07-8.57-5.13-4.30-5.25-3.91-2.85-1.01-2.51
Cash & Equivalents9.685.455.450.124.439.990.100.861.34
Total Debt------0.31--
Net Cash / Debt9.685.455.450.124.439.99-0.200.861.34
Assets10.887.819.345.098.2716.656.085.425.90
Liabilities1.531.971.791.701.671.841.952.110.71
Book Value9.365.837.553.396.6014.814.123.305.19
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Akers Biosciences Inc.
Country United States
Employees 12

Stock Information

Ticker Symbol AKER
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: AKER

Description

Akers Biosciences, Inc., together with its subsidiaries, develops, produces, and sells rapid screening and testing products designed to deliver medical devices to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. Its products include BreathScan, a disposable breath alcohol detector; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol ?Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek that detects aldehydes or oxidative stress in exhaled human breath. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.